Skip to content

Expression of RANKL and OPG in saliva of type 1 diabetes mellitus patients in Thailand : a pilot study

Expression of RANKL and OPG in saliva of type 1 diabetes mellitus patients in Thailand : a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20170929001
Enrollment
20
Registered
2017-09-29
Start date
2017-10-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 1 patients have higher expression of RANKL and lower expression of OPG than healthy subjects. Diabetes mellitus type 1 patients have poorer periodontal conditions than healthy Expression of RANKL and OPG saliva type 1 diabetes mellitus patients Probing Depth Clinical attachment level bleeding on probing

Interventions

12% have been treated at Siriraj hospital. ,Control group is healthy patients who have age&#45
matched with Type 1 diabetes mellitus patients.
Basic Science,Basic Science
Type 1 diabetes mellitus patients which HbA1C 7&#45

Sponsors

Faculty of Dentistry, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 22 Years

Inclusion criteria

Inclusion criteria: Type 1 diabetes mellitus patients which HbA1C 7-12% have been treated at Siriraj hospital. Control group is healthy patients who have age-matched with Type 1 diabetes mellitus patients.

Exclusion criteria

Exclusion criteria: 1. Patient who have been periodontitis as a manifestation of systemic diseases such as Leukocyte adhesion deficiency, Ehler danlos syndrome, neutropenia, Down syndrome, Papillon-Lefvere syndrome, Chediak-Higashi syndrome, Histiocytosis syndrome, Glycogen storage disease, Infantile genetic agranulocytosis, Cohen syndrome, Hyphosphatasia, and leukemia 2. Immunodeficiency patients 3. Patients who cannot cooperate due to a lack of psychological or emotional maturity and/or mental, physical, or medical disability 4. Patients who take medication that effecting periodontium, bleeding disorder, and infection 5. Patients who recieved bisphosphonate 6. Patients who recieved orthodontics treatment 7. Smoking 8. Pregnant 9. Patients who have deciduous teeth 10. Patients who recieved periodontal treatment within 6 months

Design outcomes

Primary

MeasureTime frame
Expression of RANKL and OPG 0 second Real time Polymerase chain Reaction

Secondary

MeasureTime frame
probing depth 0 second millimetre/PCPUNC 15, Hu-Friedy,clinical attachment level 0 seconds millimetre/PCPUNC 15, Hu-Friedy,bleeding on probing 10 seconds observe bleeding on probing/PCPUNC 15, Hu-Friedy

Countries

Thailand

Contacts

Public ContactRachanin Chairatnathrongporn

Faculty of Dentistry, Mahidol University

som11370@hotmail.com66896883119

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026